This updated meta-analysis of 29 randomized trials strengthens the case for intravenous iron over oral iron in pregnant patients with iron deficiency anemia, especially those with severe anemia, adding a newly significant reduction in peripartum blood transfusion.
IV iron outperforms oral iron for treating anemia in pregnancy.
Iron deficiency anemia (IDA) during pregnancy can adversely affect maternal and neonatal outcomes. Determining the optimal route of iron therapy is crucial for effective management. Intravenous (IV) iron was shown to significantly improve maternal hemoglobin and ferritin levels, increase neonatal iron stores, and reduce blood transfusion rates compared to oral iron, particularly in women with lower pretreatment hemoglobin levels. This study supports IV iron as a more effective treatment than oral iron for pregnant women with IDA, with fewer adverse effects, which could influence treatment protocols. IV iron improves maternal and neonatal outcomes in pregnancy-related IDA more effectively than oral iron.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Sales SK, Rajprohat S, Simon L, Hardi A, Stoll C, Benson AE, Shatzel JJ, Lo JO, Tuuli MG, Lewkowitz AK
Citation:Sales SK, Rajprohat S, Simon L, et al. Intravenous vs Oral Iron for Treating Iron Deficiency Anemia in Pregnancy: A Systematic Review and Meta-Analysis. JAMA network open. 2026;9(9):e2630657. doi:10.1001/jamanetworkopen.2026.30657